Real World Data on Management of Male LUTS
Completed
Conditions studied: Benign Prostatic Hyperplasia
In brief
This study will describe the current medical care given to men who discuss their lower urinary tract symptoms with a HCP. It will document the primary reasons for the visit, the baseline characteristics of these men, the treatment received, and the practice patterns of specifically a primary care physician managing these patients.
Key facts
- Study ID
- NCT03075449
- Run by
- Boehringer Ingelheim
- People needed
- 201
- Starts
- 2016-05-19
- Expected to finish
- 2016-12-21
- Last updated by the study team
- 2020-03-26
Who can join
Age: 18 and older, up to 100. Sex: male. Healthy volunteers: not accepted.
You may qualify if…
- Males, aged ≥18 years old.
- Having had discussion of urinary symptoms with their PCP between 15 days and 12 months prior to the date of the phone interview.
- Able to read, speak and understand English.
- Willing to provide informed consent for study participation, authorize the release of their previous 12-month medical records from their PCP for review and de-identified data entry by Mapi into an electronic study database.
You may not qualify if…
- Reported during screening that they had had their first-ever discussion of urinary symptoms with PCP within the 14 days prior to the date of the phone interview.
- Participation in a clinical research study that evaluated urinary symptoms in the past 12 months.
- Self-reported history of colorectal, bladder or prostate cancer.
- Self-reported neurologic disorders that affect bladder function, e.g., neurogenic bladder disorders due to spinal cord injury/disease, multiple sclerosis, Parkinsons disease.
- Self-reported history of radiation therapy to the lower abdominal and/or pelvic region.
Where it is running
- 527.87.10001 Boehringer Ingelheim Investigational Site — Lexington, Kentucky, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.